Long Beach-based Agilon Health Inc. raised approximately $1.07 billion through its initial public offering and saw its share price soar 38% to close at $31 on April 15, its first day of trading as a public company.
Agilon, which helps primary care physician groups cap costs for their Medicare Advantage patients, had priced its offering at $23 a share, placing 46.6 million shares on the New York Stock Exchange. That translates to net proceeds of $1.07 billion.
The IPO’s underwriters have the option over the next 30 days of buying an additional 7 million shares at the same initial offering price.
The company is controlled by an investment fund associated with Clayton Dubilier & Rice, a New York-based private equity firm. According to Agilon’s prospectus with the SEC, the CD&R fund owned 69% of all shares prior to the IPO. After the offering closes, that fund is expected to own about 58% of shares, with the exact percentage depending on how many additional shares the underwriters purchase.
Source: Los Angeles Business Journal
By Howard Fine
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.